Cyclopentyl methyl ether
Modify Date: 2024-01-04 17:35:36
Cyclopentyl methyl ether structure
|
Common Name | Cyclopentyl methyl ether | ||
|---|---|---|---|---|
| CAS Number | 5614-37-9 | Molecular Weight | 100.159 | |
| Density | 0.86 | Boiling Point | 106 ºC | |
| Molecular Formula | C6H12O | Melting Point | -140ºC | |
| MSDS | Chinese USA | Flash Point | 6.5±14.2 °C | |
| Symbol |
GHS02, GHS07 |
Signal Word | Danger | |
| Name | Cyclopentyl methyl ether |
|---|---|
| Synonym | More Synonyms |
| Density | 0.86 |
|---|---|
| Boiling Point | 106 ºC |
| Melting Point | -140ºC |
| Molecular Formula | C6H12O |
| Molecular Weight | 100.159 |
| Flash Point | 6.5±14.2 °C |
| Exact Mass | 100.088814 |
| PSA | 9.23000 |
| LogP | 1.41 |
| Vapour Pressure | 34.6±0.2 mmHg at 25°C |
| Index of Refraction | 1.423 |
| Symbol |
GHS02, GHS07 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H225-H302-H315-H319 |
| Precautionary Statements | P210-P305 + P351 + P338 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | F:Flammable;Xn:Harmful; |
| Risk Phrases | R11;R22;R36/38 |
| Safety Phrases | S26 |
| RIDADR | UN 3271 |
| Packaging Group | II |
| Hazard Class | 3.0 |
| HS Code | 2909209000 |
| Precursor 9 | |
|---|---|
| DownStream 3 | |
CAS#:67-56-1
CAS#:142-29-0
CAS#:96-41-3
CAS#:74-88-4
CAS#:930-28-9
CAS#:512-56-1
CAS#:51422-76-5
CAS#:107-13-1
CAS#:292638-85-8
CAS#:21823-29-0
CAS#:120-92-3
CAS#:788-40-9| HS Code | 2909209000 |
|---|---|
| Summary | 2909209000 other cyclanic, cyclenic or cyclotherpenic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:5.5%。General tariff:30.0% |
|
Contribution of CYP3A isoforms to dealkylation of PDE5 inhibitors: a comparison between sildenafil N-demethylation and tadalafil demethylenation.
Biol. Pharm. Bull. 38(1) , 58-65, (2015) The aim of this study was to characterize the kinetics of metabolite formation of the phosphodiesterase type-5 (PDE5) inhibitors sildenafil and tadalafil by CYP3A4, CYP3A5, and CYP3A7 isoforms. The fo... |
|
|
Replacement of dichloromethane within chromatographic purification: a guide to alternative solvents MacMillan, D.S.; et al.
Green Chem. , (2012)
|
|
|
Cyclopentyl Methyl Ether as a New and Alternative Process Solvent Watanabe, K.; Yamagiwa, N.; Torisawa, Y.
Org. Process Res. Dev. 251th ed., 11 , (2007)
|
| CYCLOPENTYL METHYL ETHER,WITH STABILIZER |
| cyclopentyl-methyl ether |
| Cyclopentyl Methyl Ether CPME |
| methyl cyclopentyl ether |
| Cyclopentane, methoxy- |
| Methoxycyclopentane |
| CPME |
| Cyclopentane,methoxy |
| Cyclopentyl methyl ether |
| Cyclpentyl methyl ether |